Search
MapLight Therapeutics Inc
MPLTAdd to Watchlist
10.760USD
-0.010-0.09%
Close 09-24 16:00（ET）
487.97MMarket Cap
LossP/E TTM
About Company
MapLight Therapeutics Inc Profile
Ticker Symbol- -
Company name- -
IPO date- -
CEO- -
Number of employees- -
Security type- -
Fiscal year-end- -
Address- -
City- -
Stock exchange- -
Country- -
Postal code- -
Phone- -
Website- -
Ticker Symbol- -
IPO date- -
CEO- -
Company Executives of MapLight Therapeutics Inc
Name
Name/Position
Position
Shareholding
Change
Dr. Anatol Kreitzer, Ph.D.
Dr. Anatol Kreitzer, Ph.D.
Chief Discovery Officer
Chief Discovery Officer
180.93K
+3.33%
Dr. Anatol Kreitzer, Ph.D.
Dr. Anatol Kreitzer, Ph.D.
Chief Discovery Officer
Chief Discovery Officer
180.93K
+3.33%
Dr. Anatol Kreitzer, Ph.D.
Dr. Anatol Kreitzer, Ph.D.
Chief Discovery Officer
Chief Discovery Officer
180.93K
+3.33%
Mr. Jonathan Gillis, CPA
Mr. Jonathan Gillis, CPA
Interim Chief Financial Officer, Chief Administrative and Chief Accounting Officer
Interim Chief Financial Officer, Chief Administrative and Chief Accounting Officer
152.36K
+5.41%
Mr. Jonathan Gillis, CPA
Mr. Jonathan Gillis, CPA
Interim Chief Financial Officer, Chief Administrative and Chief Accounting Officer
Interim Chief Financial Officer, Chief Administrative and Chief Accounting Officer
152.36K
+5.41%
Mr. Jonathan Gillis, CPA
Mr. Jonathan Gillis, CPA
Interim Chief Financial Officer, Chief Administrative and Chief Accounting Officer
Interim Chief Financial Officer, Chief Administrative and Chief Accounting Officer
152.36K
+5.41%
Ms. Erin Pennock Foff, M.D., Ph.D.
Ms. Erin Pennock Foff, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
10.16K
-538.62%
Ms. Erin Pennock Foff, M.D., Ph.D.
Ms. Erin Pennock Foff, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
10.16K
-538.62%
Ms. Erin Pennock Foff, M.D., Ph.D.
Ms. Erin Pennock Foff, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
10.16K
-538.62%
Mr. Martin Babler
Mr. Martin Babler
Independent Director
Independent Director
7.86K
--
View more
Name
Name/Position
Position
Shareholding
Change
Dr. Anatol Kreitzer, Ph.D.
Dr. Anatol Kreitzer, Ph.D.
Chief Discovery Officer
Chief Discovery Officer
180.93K
+3.33%
Dr. Anatol Kreitzer, Ph.D.
Dr. Anatol Kreitzer, Ph.D.
Chief Discovery Officer
Chief Discovery Officer
180.93K
+3.33%
Dr. Anatol Kreitzer, Ph.D.
Dr. Anatol Kreitzer, Ph.D.
Chief Discovery Officer
Chief Discovery Officer
180.93K
+3.33%
Mr. Jonathan Gillis, CPA
Mr. Jonathan Gillis, CPA
Interim Chief Financial Officer, Chief Administrative and Chief Accounting Officer
Interim Chief Financial Officer, Chief Administrative and Chief Accounting Officer
152.36K
+5.41%
Mr. Jonathan Gillis, CPA
Mr. Jonathan Gillis, CPA
Interim Chief Financial Officer, Chief Administrative and Chief Accounting Officer
Interim Chief Financial Officer, Chief Administrative and Chief Accounting Officer
152.36K
+5.41%
Mr. Jonathan Gillis, CPA
Mr. Jonathan Gillis, CPA
Interim Chief Financial Officer, Chief Administrative and Chief Accounting Officer
Interim Chief Financial Officer, Chief Administrative and Chief Accounting Officer
152.36K
+5.41%
FAQs
Who are the top five shareholders of MapLight Therapeutics Inc?
The top five shareholders of MapLight Therapeutics Inc are: Dr. Anatol Kreitzer, Ph.D.